Energy metabolism in reperfused heart muscle: metabolic correlates to return of function

An important question in energy metabolism of the reperfused, previously ischemic myocardium is whether the return of a normal tissue adenosine triphosphate (ATP) content is a prerequisite for normal rates of oxygen consumption (that is, ATP turnover) and cardiac function. To study this problem, isolated working rat hearts were perfused with bicarbonate saline solution containing glucose (10 mM) at near physiologic work load. After 20 minutes, hearts were made totally ischemic by clamping the aortic and atrial lines for 5, 10 or 20 minutes and then were reperfused for another 10 minutes. Heart rate, aortic pressure, cardiac output and myocardial oxygen consumption were measured continuously. Adenine nucleotides, phosphocreatine, glycogen and the products of glycolysis were determined in freeze-clamped tissue extracts. Functional recovery was assessed by return of aortic pressure and oxygen consumption to preischemic values. Time required for return of function after reperfusion was 90 seconds after 5 minutes and 124 seconds after 10 minutes of ischemia. No recovery was observed after 20 minutes of ischemia. Tissue ATP content decreased significantly at the end of 5 (-38%) and 10 (-56%) minutes of ischemia and did not increase significantly at return of aortic pressure and oxygen consumption to preischemic values. Glycogen stores decreased by more than 50% at the end of 10 minutes of ischemia and did not normalize on recovery. In contrast to ATP or glycogen, the phosphocreatine content decreased to even lower levels at the end of ischemia, but returned to levels higher than the control level after recovery from 5 to 10 minutes of ischemia in association with return of function.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				L. De Luca, A. Mebazaa, G. Filippatos, J. T. Parissis, M. Bohm, A. A. Voors, M. Nieminen, F. Zannad, A. Rhodes, A. El-Banayosy, et al. Overview of emerging pharmacologic agents for acute heart failure syndromes Eur J Heart Fail, February 1, 2008; 10(2): 201 - 213. [Abstract] [Full Text] [PDF]

				S. Sharma, P. H. Guthrie, S. S. Chan, S. Haq, and H. Taegtmeyer Glucose phosphorylation is required for insulin-dependent mTOR signalling in the heart Cardiovasc Res, October 1, 2007; 76(1): 71 - 80. [Abstract] [Full Text] [PDF]

				L. Lee, J. Horowitz, and M. Frenneaux Metabolic manipulation in ischaemic heart disease, a novel approach to treatment Eur. Heart J., April 2, 2004; 25(8): 634 - 641. [Abstract] [Full Text] [PDF]

				R. J. Gumina, D. Pucar, P. Bast, D. M. Hodgson, C. E. Kurtz, P. P. Dzeja, T. Miki, S. Seino, and A. Terzic Knockout of Kir6.2 negates ischemic preconditioning-induced protection of myocardial energetics Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2106 - H2113. [Abstract] [Full Text] [PDF]

				T. Doenst, C. Schlensak, and F. Beyersdorf Cardioplegia in pediatric cardiac surgery: do we believe in magic? Ann. Thorac. Surg., May 1, 2003; 75(5): 1668 - 1677. [Abstract] [Full Text] [PDF]

				S. C. Stoica, D. K. Satchithananda, C. Atkinson, P. A. White, A. N. Redington, M. Goddard, T. Kealey, and S. R. Large The energy metabolism in the right and left ventricles of human donor hearts across transplantation Eur. J. Cardiothorac. Surg., April 1, 2003; 23(4): 503 - 512. [Abstract] [Full Text] [PDF]

				L.J de Windt, K Cox, L Hofstra, and P.A Doevendans Molecular and genetic aspects of cardiac fatty acid homeostasis in health and disease Eur. Heart J., May 2, 2002; 23(10): 774 - 787. [Full Text] [PDF]

				Q. Liu, J. C. Docherty, J. C. T. Rendell, A. S. Clanachan, and G. D. Lopaschuk High levels of fatty acids delay the recoveryof intracellular pH and cardiac efficiency inpost-ischemic hearts by inhibiting glucose oxidation J. Am. Coll. Cardiol., February 20, 2002; 39(4): 718 - 725. [Abstract] [Full Text] [PDF]

				H. Wiggers, M. Noreng, P. K. Paulsen, M. Bottcher, H. Egeblad, T. T. Nielsen, and H. E. Botker Energy stores and metabolites in chronic reversibly and irreversibly dysfunctional myocardium in humans J. Am. Coll. Cardiol., January 1, 2001; 37(1): 100 - 108. [Abstract] [Full Text] [PDF]

				H. Taegtmeyer Metabolism--the lost child of cardiology J. Am. Coll. Cardiol., October 1, 2000; 36(4): 1386 - 1388. [Full Text] [PDF]

				C. Ceconi, P. Bernocchi, A. Boraso, A. Cargnoni, P. Pepi, S. Curello, and R. Ferrari New insights on myocardial pyridine nucleotides and thiol redox state in ischemia and reperfusion damage Cardiovasc Res, August 18, 2000; 47(3): 586 - 594. [Abstract] [Full Text] [PDF]

				C. Depre and H. Taegtmeyer Metabolic aspects of programmed cell survival and cell death in the heart Cardiovasc Res, February 1, 2000; 45(3): 538 - 548. [Abstract] [Full Text] [PDF]

				D. F. Pauly and C. J. Pepine D-Ribose as a Supplement for Cardiac Energy Metabolism Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(4): 249 - 258. [Abstract] [PDF]

				H. G. Pietersen, C. J. M. Langenberg, G. Geskes, A. Kester, S. d. Lange, G. J. Van der Vusse, A. J. M. Wagenmakers, and P. B. Soeters MYOCARDIAL SUBSTRATE UPTAKE AND OXIDATION DURING AND AFTER ROUTINECARDIAC SURGERY J. Thorac. Cardiovasc. Surg., July 1, 1999; 118(1): 71 - 81. [Abstract] [Full Text] [PDF]

				T. Doenst, R. T. Richwine, M. S. Bray, G. W. Goodwin, O.H. Frazier, and H. Taegtmeyer Insulin improves functional and metabolic recovery of reperfused working rat heart Ann. Thorac. Surg., June 1, 1999; 67(6): 1682 - 1688. [Abstract] [Full Text] [PDF]

				R. Bolli and E. Marban Molecular and Cellular Mechanisms of Myocardial Stunning Physiol Rev, April 1, 1999; 79(2): 609 - 634. [Abstract] [Full Text] [PDF]

				P. D Verdouw, M. A van den Doel, S. de Zeeuw, and D. J Duncker Animal models in the study of myocardial ischaemia and ischaemic syndromes Cardiovasc Res, July 1, 1998; 39(1): 121 - 135. [Full Text] [PDF]

				T. M. Chen, G. W. Goodwin, P. H. Guthrie, and H. Taegtmeyer Effects of insulin on glucose uptake by rat hearts during and after coronary flow reduction Am J Physiol Heart Circ Physiol, November 1, 1997; 273(5): H2170 - H2177. [Abstract] [Full Text] [PDF]